Company News

Solazyme Maintains in Fiscal 2011

Posts annual revenue of $39.0 million.

Author Image

By: TOM BRANNA

Editor

Solazyme, Inc. posted financial results for the fourth quarter and fiscal year ended Dec. 31, 2011 and recent key corporate highlights. “In 2011, Solazyme made significant progress toward commercializing our valuable technology platform, including launching our Algenist skin care line and our Solazyme Roquette Nutritionals business,” said Jonathan Wolfson, CEO, Solazyme. “Recently, we commenced operations at our manufacturing plant in Peoria, Illinois and Solazyme Roquette Nutritionals ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters